208 related articles for article (PubMed ID: 33640171)
41. End-to-end versus end-to-side esophagogastrostomy after esophageal cancer resection: a prospective randomized study.
Nederlof N; Tilanus HW; Tran TC; Hop WC; Wijnhoven BP; de Jonge J
Ann Surg; 2011 Aug; 254(2):226-33. PubMed ID: 21725230
[TBL] [Abstract][Full Text] [Related]
42. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
[TBL] [Abstract][Full Text] [Related]
43. [Adenocarcinoma of the esophagogastric junction: retrospective analysis of 39 patients].
Butte JM; Becker F; Visscher A; Waugh E; Meneses M; Court I; Parada H; DE LA Fuente H
Rev Med Chil; 2010 Jan; 138(1):53-60. PubMed ID: 20361151
[TBL] [Abstract][Full Text] [Related]
44. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
[TBL] [Abstract][Full Text] [Related]
45. Transthoracic vs transhiatal surgery for cancer of the esophagogastric junction: a meta-analysis.
Wei MT; Zhang YC; Deng XB; Yang TH; He YZ; Wang ZQ
World J Gastroenterol; 2014 Aug; 20(29):10183-92. PubMed ID: 25110447
[TBL] [Abstract][Full Text] [Related]
46. Surgical approach and results of surgery in adenocarcinoma of the gastro-oesophageal junction.
Ti TK
Singapore Med J; 2000 Jan; 41(1):14-8. PubMed ID: 10783674
[TBL] [Abstract][Full Text] [Related]
47. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
48. The Postoperative outcomes of thoracoscopic-laparoscopic Ivor-Lewis surgery plus D2 celiac lymphadenectomy for patients with adenocarcinoma of the esophagogastric junction.
Li KK; Bao T; Wang YJ; Liu XH; Guo W
Surg Endosc; 2020 Nov; 34(11):4957-4966. PubMed ID: 31823049
[TBL] [Abstract][Full Text] [Related]
49. Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction.
Reeh M; Mina S; Bockhorn M; Kutup A; Nentwich MF; Marx A; Sauter G; Rösch T; Izbicki JR; Bogoevski D
Br J Surg; 2012 Oct; 99(10):1406-14. PubMed ID: 22961520
[TBL] [Abstract][Full Text] [Related]
50. Selective management of intrathoracic anastomotic leak after esophagectomy.
Crestanello JA; Deschamps C; Cassivi SD; Nichols FC; Allen MS; Schleck C; Pairolero PC
J Thorac Cardiovasc Surg; 2005 Feb; 129(2):254-60. PubMed ID: 15678033
[TBL] [Abstract][Full Text] [Related]
51. Age-related changes in muscle quality and development of diagnostic cutoff points for myosteatosis in lumbar skeletal muscles measured by CT scan.
Kim HK; Kim KW; Kim EH; Lee MJ; Bae SJ; Ko Y; Park T; Shin Y; Kim YJ; Choe J
Clin Nutr; 2021 Jun; 40(6):4022-4028. PubMed ID: 34144412
[TBL] [Abstract][Full Text] [Related]
52. Surgical Protocol for Esophageal Adenocarcinoma.
Law S
Methods Mol Biol; 2018; 1756():35-50. PubMed ID: 29600358
[TBL] [Abstract][Full Text] [Related]
53. Myosteatosis in a systemic inflammation-dependent manner predicts favorable survival outcomes in locally advanced esophageal cancer.
Gabiatti CTB; Martins MCL; Miyazaki DL; Silva LP; Lascala F; Macedo LT; Mendes MCS; Carvalheira JBC
Cancer Med; 2019 Nov; 8(16):6967-6976. PubMed ID: 31571402
[TBL] [Abstract][Full Text] [Related]
54. Preoperative Low Weight Affects Long-term Outcomes Following Curative Gastrectomy for Gastric Cancer.
Komatsu S; Kosuga T; Kubota T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
Anticancer Res; 2018 Sep; 38(9):5331-5337. PubMed ID: 30194185
[TBL] [Abstract][Full Text] [Related]
55. Cardiopulmonary exercise testing has greater prognostic value than sarcopenia in oesophago-gastric cancer patients undergoing neoadjuvant therapy and surgical resection.
West MA; Baker WC; Rahman S; Munro A; Jack S; Grocott MP; Underwood TJ; Levett DZ;
J Surg Oncol; 2021 Dec; 124(8):1306-1316. PubMed ID: 34463378
[TBL] [Abstract][Full Text] [Related]
56. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
57. Effect of muscle depletion on survival in peripheral arterial occlusive disease: Quality over quantity.
Vedder IR; Levolger S; Dierckx RAJO; Zeebregts CJ; de Vries JPM; Viddeleer AR; Bokkers RPH
J Vasc Surg; 2020 Dec; 72(6):2006-2016.e1. PubMed ID: 32330596
[TBL] [Abstract][Full Text] [Related]
58. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
59. Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis.
Rinninella E; Cintoni M; Raoul P; Pozzo C; Strippoli A; Bria E; Tortora G; Gasbarrini A; Mele MC
Clin Nutr; 2020 Jul; 39(7):2045-2054. PubMed ID: 31718876
[TBL] [Abstract][Full Text] [Related]
60. RISK FACTORS FOR SEVERE POSTOPERATIVE COMPLICATIONS AFTER GASTRECTOMY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION CANCERS.
Norero E; Quezada JL; Cerda J; Ceroni M; Martinez C; Mejía R; Muñoz R; Araos F; González P; Díaz A
Arq Bras Cir Dig; 2019; 32(4):e1473. PubMed ID: 31859926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
